Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.laxmi.com | |
Market Cap | 7,064.03 Cr. | |
Enterprise Value(EV) | 7,163.34 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.96 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 44.68 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 26.11 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 52.12 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 5.11 | Calculated using Price: 266.40 |
Dividend Yield | 0.26 | Period Ending 2022-03 |
No. of Shares Subscribed | 26.52 Cr. | 265,166,424 Shares |
FaceValue | 2 | |
Company Profile | ||
The company is a specialty chemical manufacturer that operates in 2 business segments; Acetyl Intermediates (AI) and Specialty Intermediates (SI). |
1 Day |
|
-0.32% |
1 Week |
|
-7.93% |
1 Month |
|
-10.30% |
3 Month |
|
-15.78% |
6 Month |
|
-14.35% |
1 Year |
|
-38.93% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 6.26 | 10.64 | 12.01 | 26.18 | 22.28 | 17.45 | 16.02 | 17.44 | 22.27 | |
Return on Capital Employed (%) | 9.45 | 12.65 | 11.63 | 21.56 | 24.54 | 19.10 | 16.16 | 20.14 | 25.81 | |
Return on Assets (%) | 2.09 | 3.56 | 4.29 | 11.13 | 10.07 | 7.65 | 6.74 | 8.74 | 12.50 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 427 | 1,035 | 1,301 | 1,355 | |
Non Curr. Liab. | 113 | 35 | 32 | 54 | |
Curr. Liab. | 529 | 768 | 932 | 746 | |
Minority Int. | 0 | 0 | 0 | 0 | |
Equity & Liab. | 1,069 | 1,838 | 2,265 | 2,154 | |
Non Curr. Assets | 431 | 533 | 792 | 935 | |
Curr. Assets | 639 | 1,305 | 1,473 | 1,220 | |
Misc. Exp. not W/O | |||||
Total Assets | 1,069 | 1,838 | 2,265 | 2,154 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 858 | 1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,943 | |
Other Income | 1 | 1 | 2 | 2 | 3 | 6 | 5 | 5 | 15 | 10 | |
Total Income | 859 | 1,075 | 1,048 | 1,078 | 1,379 | 1,574 | 1,539 | 1,773 | 3,099 | 2,953 | |
Total Expenditure | -789 | -987 | -966 | -955 | -1,224 | -1,414 | -1,418 | -1,549 | -2,713 | -2,685 | |
PBIDT | 71 | 88 | 82 | 123 | 154 | 161 | 121 | 224 | 386 | 268 | |
Interest | -23 | -27 | -19 | -14 | -11 | -19 | -17 | -19 | -19 | -17 | |
Depreciation | -32 | -30 | -29 | -28 | -29 | -44 | -49 | -47 | -49 | -64 | |
Taxation | -4 | -9 | -8 | -10 | -38 | -25 | -11 | -31 | -61 | -29 | |
Exceptional Items | 0 | 0 | 26 | ||||||||
PAT | 12 | 21 | 27 | 71 | 76 | 72 | 70 | 127 | 256 | 158 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 11 | 21 | 27 | 71 | 76 | 72 | 70 | 127 | 256 | 158 | |
Adjusted EPS | 2 | 3 | 4 | 11 | 12 | 3 | 3 | 5 | 10 | 6 |
Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 196 | 106 | 46 | |
Cash Fr. Inv. | -56 | -641 | 74 | |
Cash Fr. Finan. | -123 | 527 | -124 | |
Net Change | 16 | -7 | -5 | |
Cash & Cash Eqvt | 24 | 17 | 33 |
Fri, 27 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to regulation 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please see enclosed published newspaper advertisement of the standalone and consolidated financial results of the Company for the quarter ended December 31 2022.We request you to take the above on record. |
Fri, 27 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that the Company participated in the investor conference as enclosed.No Unpublished Price Sensitive Information was shared / discussed in the meeting with the investors.Further please see enclosed the transcript of the Investor Presentation for Q3 FY23.We request you to take the above on record. |
Wed, 25 Jan 2023
Announcement under Regulation 30 (LODR)-Monitoring Agency Report Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that there has been no deviation in the utilization of IPO Proceeds from the objects stated in the prospectus dated March 18 2021. In this regard please see enclosed Monitoring Agency Report issued by Axis Bank Limited (Monitoring Agent) for the quarter ended December 31 2022. We request you to take the above on record. |
Tue, 31 Jan 2023 |
|
|
|
|
|